Table 1.

Anthropometric and biochemical data of subjects

	Control subjects	Type 2 diabetic patients
	(n = 43)	(n = 45)
Male/female ratio	23/20	21/24
Age	30–54 yr	30–55
BMI (kg/m2)	25.19 ± 1.90	26.38 ± 0.92
Duration of disease (years)	-	9.9 ± 2.3
Insulin treatment (% patients receiving insulin treatment)	No	Yes (100%)
Fasting glucose (mM)	5.05 ± 0.17	9.55 ± 1.11**
HbA1C (%)	4.25 ± 0.25	9.57 ± 1.56**
Insulinemia (µUI/ml)	5.46 ± 0.77	10.93 ± 0.64**
Urea (mM)	5.33 ± 0.33	5.49 ± 0.17
Creatinemia (µM)	95.38 ± 6.31	98.30 ± 6.10
Total cholesterol (mM)	5.64 ± 0.41	4.35 ± 0.36*
HDL-cholesterol (mM)	1.63 ± 0.03	1.55 ± 0.05
Triglycerides (mM)	1.23 ± 0.13	0.83 ± 0.11*

BMI: Body Mass Index; HDL: High Density Lipoproteins; HbA1c: glycosylated hemoglobin. Values are means ± SEM. n = 43 healthy control subjects; n = 45 type 2 diabetic patients. *p<0.05 and **p<0.01 indicate significant difference between type 2 diabetic patients and healthy control subjects. Ranges of normal values: Fasting glucose: 3.88–6.10 mM (0.7–1.10 g/L); Total-cholesterol: 3.23–6.46 mM (1.25–2.50 g/L) ; HDL-cholesterol: 1.16–1.94 mM (0.45–0.75 g/L); Triglycerides: 0.57–1.71 mM (0.50–1.50 g/L); Urea: 2.50–7.49 mM (0.15–0.45 g/L) ; Creatinine: 53.04–123.76 µM (6–14 mg/L) ; HbA1c: 4–6 % ; Insulin: 1.21–14.5 µUI/ml.